BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8247198)

  • 1. Simultaneous occurrence of IgA nephropathy and sarcoidosis in the context of pre-existent minimal change nephrotic syndrome.
    Anwar N; Gokal R
    Nephron; 1993; 65(2):310-2. PubMed ID: 8247198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease?
    Westhoff TH; Waldherr R; Loddenkemper C; Ries W; Zidek W; van der Giet M
    Clin Nephrol; 2006 Mar; 65(3):203-7. PubMed ID: 16550751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal change variants with mesangial IgA deposits.
    Matsukura H; Miya K; Arai M; Miyawaki T; Inaba S
    Clin Nephrol; 2007 Nov; 68(5):337-8. PubMed ID: 18044269
    [No Abstract]   [Full Text] [Related]  

  • 4. [Minimal change nephropathy and IgA deposits associated with a Sezary syndrome].
    Bichon A; Brue A; Godefroy R; Sallee M; Daniel L; Farnarier C; Gobin N; Abed S; Richard MA; Villani P; Malissen N; Daumas A
    Rev Med Interne; 2022 Jan; 43(1):48-53. PubMed ID: 34419323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MCNS, which secondary developed into incidental IgA nephropathy--a case report].
    Tsunehisa N; Takemura T; Inui T; Kamiya H
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1095-9. PubMed ID: 1289609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous occurrence of minimal change glomerular disease, sarcoidosis and Hashimoto's thyroiditis.
    Nishimoto A; Tomiyoshi Y; Sakemi T; Kanegae F; Nakamura M; Ikeda Y; Shimazu K; Yonemitsu N
    Am J Nephrol; 2000; 20(5):425-8. PubMed ID: 11093004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of concomitant nephrotic IgA nephropathy and minimal change disease in children.
    Shen H; Gu W; Mao J; Zhu X; Jin X; Fu H; Liu A; Shu Q; Du L
    Nephron; 2015; 130(1):21-8. PubMed ID: 25924689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-pathological evaluation of mesangial IgA deposition of minimal change with nephrotic syndrome].
    Hamaguchi K; Tuchida H; Suzuki S; Miura Y; Nakazawa R; Suhara Y; Mimura N
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1071-7. PubMed ID: 2287099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesangial immunoglobulin A deposits in minimal change nephrotic syndrome: a report of an older patient and review of the literature.
    Clive DM; Galvanek EG; Silva FG
    Am J Nephrol; 1990; 10(1):31-6. PubMed ID: 2111636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IGA-nephropathy with nephrotic syndrome as an extrapulmonary manifestation of sarcoidosis].
    Kornev BM; Kozlovskaia LV; Fomin VV; Popova EN; Moiseev SV; Taronishvili OI; Kondarova OV; Varshavskiĭ VA; Golitsina EP
    Klin Med (Mosk); 2005; 83(6):83-6. PubMed ID: 16075654
    [No Abstract]   [Full Text] [Related]  

  • 11. Pattern of double glomerulopathies. A clinicopathologic study in nine nondiabetic patients.
    Monga G; Mazzucco G; Barbiano di Belgiojoso G; Confalonieri R; Sacchi G; Bertani T
    Nephron; 1990; 56(1):73-80. PubMed ID: 2234252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidental mesangial IgA deposition in minimal change nephrotic syndrome(MCNS)].
    Tsukada M; Honda K; Nitta K; Yumura W; Nihei H
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):681-8. PubMed ID: 14631763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
    Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
    J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous presentation of IgA nephropathy and sarcoidosis.
    Murray FE; Lombard MG; Donohoe JF; Doyle GD; Campbell E; Alton BG
    Sarcoidosis; 1987 Sep; 4(2):134-6. PubMed ID: 3659616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoelectric focusing and selectivity index in IgA nephrotic syndrome.
    Woo KT; Lau YK; Wong KS; Lee GS; Chin YM; Chiang GS; Lim CH
    Nephron; 1994; 67(4):408-13. PubMed ID: 7969672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-sensitive nephrotic syndrome with mesangial IgA deposits: a separate entity? Observation of two cases.
    Barbiano di Belgiojoso G; Mazzucco G; Casanova S; Radaelli L; Monga G; Minetti L
    Am J Nephrol; 1986; 6(2):141-5. PubMed ID: 3518456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of mesangial IgA deposition in minimal change nephrotic syndrome: a study of 60 cases.
    Choi J; Jeong HJ; Lee HY; Kim PK; Lee JS; Han DS
    Yonsei Med J; 1990 Sep; 31(3):258-63. PubMed ID: 2281685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of nephrotic syndrome in patients with glomerulonephritis.
    Sonkodi S; Tichy B; Mágori A; Ormos J
    Acta Med Hung; 1986; 43(3):311-3. PubMed ID: 3588169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Guillain-Barré syndrome developed minimal change nephrotic syndrome simultaneously.
    Kitamura H; Nakano T; Kakihara M; Nishino M; Isshiki K; Kawano K; Yamauchi A; Imai E; Kamada T; Abe H
    Am J Nephrol; 1998; 18(2):151-4. PubMed ID: 9569959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.